Member Info for CooperD

Jadam,

Investors would be hard pushed to find another AIM stock with this much potential with todays Mcap. Not a complaint from me though as I now have a cracking holding and will do very well when we hit the CEO's £500 mill ++ Mcap target.

I think he's going to have to revise that up though because the Covid situation is only begining. The amount of testing required in order to provide safe working environments for employees is going to go stratospheric in order to keep employees safe at work.

People will not want to be put at risk and will demanding that testing is deemed mandatory and if that does happen how often do you test? One example is ferrari, they have announced they are to start production again and staff can request to be tested which 95% of them have requested be done. Ferrai were asked if this was expensive and the reply was no, it's an investment. Imo this will need to be done at the very least once a week allthough I would suggest daily in order to keep everyone safe.

Imo that means Yougene are very well placed to capatilise on that uptake due to their state of the art labs and capabilities. Again, it's a side line to the BAU but a nice one that anyone with any sense would grab as Lyn Rees has done.

Soon as the seller goes, we go north. Not be long till these prices looked cheap to thoase looking in.

slightly under 49919

The morg,

That's the way I read it too but again, confirmation in the form of an rns would be good. Not a problem for me though as I feel good about the whole thing. it appears to me that it's all going to plan here. The recruitment drive explains a lot, the tweets give an idea aslo.

it's all systems go as far as I can see.

That was in reference to the NHS and PHE. If they didn't take up the offer we may have increased our output for NCYT.

Seaking

completely agree but I think it's a talking point due to the fact we were doing so well without any covid revunes in the last set of results. Basically having revenues from covid now hitting the bottom line without impacting on BAU means we will be further ahead that we expected.

At the very least it's a huge positive to be able to generate additonal income.

Pacman,

there's every chance with the urgency around testing that we are working flat out on covid testing.

A update needed to get to grips with exactly where we are would be good but as mentioned earlier we should here something this week possibly. It's good news that we're getting some additonal income so nothing but gravy for us.

Pacman

That helps unsterstand where we are a bit. Hopefully get an update at some point soon as to what that means for us financially.

Pacman,

I agree and didn't want to suggest that but I think he's about to playa blinder.

Fingers crossed but I smell a game chnging rns shortly.

FT

Looking forward to that.

Not a bad start thus far. I'm expecting news this week too. Also aware that certain news items might be delayed due to the covid 19 situation. Regardless though it's all good for when it does land.

Fair enough, just never seen you post before. atb

Natdan

Didn't think he was an investor. I haven't seen him post anything of relevance.

Your last post was spot on.

These boards don't have throuw up some nuggets.

Thanks for the imformative post.

Lyn rees also stated we have capcity to take on other covid 19 related contracts should our services be required. The platforms we use for our reproductive testing can easily be switched to support the covid 19 testing.

So whether it's core business or additonal covid 19 business Ygen are on the case and thriving.

Ygen are assiting NCYT with the manufacturng of Covid 19 test kits and have been coining in revenue.

Manufacturing or owning the IP is the only way to make money from the current pandemic.

Ygen are in on it and getting on with BAU at the same time.

Winner winner.

The last rns they got was like the last rights. The board kept trying to dress it up as some kind of good news lol

Once you buy over they're your locked in and can only get out if more mugs buy.

The whole thing is based on a study and if the study is succesfull and then they will start look at devleopment. The whoe staement is full of if's and could's but with nothing of any substance and even if they did manage to get through all the various stages covid 19 will be history by the time they do anything.

It's one to avoid on a big scale.

Better not be monday.

I wanted to get a few more before we start and motor. If it does land on monday I have a good enough holding to sit tight and enjoy the rise so best of both worlds. If I can get more though then that would be great.

Ducati

Just following on from your post with regards to testing more than once.

Hospital to care home transfers alone now need to be tested twice and have two negative test results before the transefer can be completed to the care home. This is going to be replicated and amplified on many fronts in many secorors and industries as we try and repoen.

Testing is the only way forward for now and as such it appears we will benefit from this. How much we benefit I have no idea but as I stated before a small % of the mioons NCYT are generating would be gravy for us.

The core business is going great guns and the fact we have been on a constant recruitment drive tell you the business is growing at a fair rate of knots.

One other thing regarding the US. Lyn stated in the recent video interview with BRR media that the only stumbling block atm for the US market was the travel restrictions. Once travel restrictions are lifted he expected to start and fulfill the potetnial in the US.